Edgewise Therapeutics grants inducement equity awards covering 11,251 shares to three new employees
EWTX•Edgewise Therapeutics granted three new non-executive employees equity awards covering 11,251 shares on Sept. 30, 2026, including options for 7,500 shares priced at $40.60 each and restricted stock units for 3,751 shares.
1. Award details
The options vest 25% on each employee’s one-year start-date anniversary and then monthly over 48 months, subject to continued service. The restricted stock units vest in four equal annual installments from the grant date.
Related News
SAB Biotherapeutics presents Phase 1 data for SAB-142 in Stage 3 type 1 diabetes at CRC 2026
SABS•
Alpha Cognition says CONVERGE real-world study shows 79.1% of ZUNVEYL users in long-term care reach therapeutic dose
ACOG•
